The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

covid vaccine

Forums covid vaccine

  • Post
    poppymac
    Participant
    maybe i’m out of order or wrong to think this but has anyone noticed how quick they found a vaccine compared to progress treating cancer

    Loading spinner
Viewing 3 reply threads
  • Replies
      tkoss
      Participant
      i am still marveling at the cost of 1 dose of Opvidio.

      Loading spinner
        poppymac
        Participant
        in southern ireland i’ve heard pembro is 7000 euros per dose and as low as 4000 in uk

        Loading spinner
        tkoss
        Participant
        for a 240mg infusion the clinic charges $19,000 and insurance actually gets $9500. i once saw a price for a dose listed as $6500.000

        they are advertising the hell out of Opvidio and Keytruda on national TV. probably what a $50m campaign or more?

        Loading spinner
        poppymac
        Participant
        do u mean insurance pays 9500 of the 19000 and if so who pays the remainder

        Loading spinner
        tkoss
        Participant
        Welcome to the Ponzi scheme that is US health care. the hospital has a list price, insurers negotiate with them and ignore the list price. here is the rub; why do they have a list price so high? well you can always lower teh price i guess. like new cars.
        I assume if your someone without Health Insurance they would bill you full price. $9500 seems fair for the infusion, if a dose of opvido really cost $6500. i get a few thousand dollars worth of nurses and technology and band-aids, etc.

        does a does of opvido cost SBM $5500 to make and they mark it up $1000? or does it cost $9.95 to make and they mark it up $9490.05 . no one knows and they aren’t telling.

        Loading spinner
        tkoss
        Participant
        ps: i just enrolled for 2020. the premium price jumped over $100 a month to $1100 and the out of pocket maximum doubled.

        no warning, no explanation.

        Loading spinner
        poppymac
        Participant
        in nhs england they initially agreed a big price but then when they saw results the cut it,in southern ireland they wanted to pay by success but that didn’t happen as only 1 in 5 had a good response

        Loading spinner
        MelMel
        Participant
        Here is something more you can marvel on.

        https://www.fiercepharma.com/pharma/can-23b-market-for-pd-1-blockers-cancer-grow-pan-adjuvant-use-key-report

        Immuno-oncology drugs that block the checkpoint PD-1 have been one of the biggest success stories in the pharma industry, creating blockbusters like Bristol Myers Squibb’s Opdivo and Merck’s Keytruda. The embrace of the drugs to treat many types of metastatic cancer has created a $23 billion market.

        But that market is slowing, raising a worrisome question on Wall Street: How can companies like BMS and Merck continue to fuel the growth of PD-1 inhibitors?

        The answer is in “pan-adjuvant” settings, in which patients are given PD-1 blockers before and/or after surgery along with other treatments to boost their chances of beating their cancer, analysts at Bernstein said in a note to investors earlier this week. For Merck and BMS, pan-adjuvant approvals could add at least $12 billion to their annual haul from PD-1 drugs in the next eight years—with the lion’s share of that going to Keytruda, they predicted.

        Loading spinner
        MelMel
        Participant
        Melanoma is an extremely small market. Of 200,000 diagnoses per year, only stage IV and some stage III utilize the drugs which is even a much smaller amount of patients. These pharma companies require huge markets so they are looking to get approvals for their drugs in other areas to treat different cancers and as pan adjuvant treatment pre and post surgery. This would greatly expand their profits since the above link clearly shows how that particular drug market is starting to rapidly slow.

        The prices are whatever the market will bear.
        I used to live in Canada. A migrane pill was $11 Canadian per pill and here in MI one pill was $61 U.S. Viroptic eye drops are $39 Canadian in Canada versus $365 US here. Now tell me this is not absolute craziness? It literally makes your head spin.

        If you have insurance, the prices are set. If you have no insurance some of the hospitals give you an automatic 40 % off. So it is what you can bargain for. I think there is lots of room for them to manouver. I get the feeling that they are operating like banks. They make their money in the first few infusions and the rest is just gravy.

        Loading spinner
      MelMel
      Participant
      An excellent question and here is an article which may provide an answer.

      “CANCER NEXT?

      Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines.

      Biontech is testing an anti-melanoma mRNA with Swiss pharmaceutical giant Roche in a Phase II trial.

      Among Moderna’s most advanced projects, besides its COVID-19 vaccine, are mRNA compounds to treat ovarian cancer or Myocardial ischemia, which are also in the second test phase.

      None of the potential mRNA cancer therapies have reached the critical large-scale Phase III trials, however, and Kariko acknowledges that cancer presents a bigger challenge.
      While a virus is a foreign intruder, cancer cells, however malignant, come from within the body, making them tougher to seek out and expose so they can be attacked.

      “Sometimes cancer is just caused by gene and chromosome duplication and then everything about it looks normal and the cell is just dividing more than it should,” she said.

      “The moment a pathogen’s genomic sequence is known, synthetic mRNAs can be designed that encode key parts of the virus, such as the coronavirus’s potentially lethal spike protein.”

      https://mobile-reuters-com.cdn.ampproject.org/v/s/mobile.reuters.com/article/amp/idUKKBN27W2PJ?amp_js_v=a6&amp_gsa=1&usqp=mq331AQHKAFQArABIA%3D%3D#aoh=16070458187642&referrer=https%3A%2F%2Fwww.google.com&amp_tf=From%20%251%24s&ampshare=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-vaccines-technolog-idUSKBN27W2PJ

      So they are trying and Dr. Kariko and others who have been laughed and ridiculed by other scientists for years come out as winners in the end.

      Melanie

      Loading spinner
      JudiAU
      Participant
      The shameful thing is not cancer. Progress in cancer,, particularly in melanoma, is made every year and god knows I’m alive because of it. What really comes to mind is the sort pervasive, life-ruining, diseases that are endemic in “third world” countries than science rarely pays attention to because it is not profitable, well funded, or interesting.

      Loading spinner
Viewing 3 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.